Literature DB >> 21183925

Follow-up cervical length in asymptomatic high-risk women and the risk of spontaneous preterm birth.

J M G Crane1, D Hutchens.   

Abstract

OBJECTIVE: To determine whether further cervical length shortening by transvaginal ultrasonography in asymptomatic high-risk women with a short cervical length adds additional predictive value for spontaneous preterm birth and perinatal morbidity. STUDY
DESIGN: Women with a history of spontaneous preterm birth, loop electrosurgical excision procedure, cone biopsy or uterine anomaly, who were pregnant with singleton gestations and were found by transvaginal ultrasonography to have a cervical length <3.0 cm at 20 to 28 weeks' gestation, and who underwent a follow-up cervical length within 3 weeks were evaluated, comparing those with further cervical length shortening (>10%) to those without further shortening. Primary outcomes were spontaneous preterm birth <35 weeks' gestation and perinatal morbidity. Secondary outcomes included spontaneous preterm birth <37 weeks, <34 weeks, <32 weeks, birth weight <2500 g, maternal and other neonatal outcomes. RESULT: Compared with women without further cervical shortening, those with further shortening were found by univariate analyses to have higher rates of spontaneous preterm birth <35 weeks (34.8 versus 8.5%, P = 0.014), <37 weeks (56.5 versus 21.3%, P = 0.003), <34 weeks (30.4 versus 2.1%, P = 0.001), <32 weeks (21.7 versus 0%, P = 0.003), birth weight <2500 g (60.9 versus 17.0%, P<0.0001), neonatal intensive care unit admission (47.8 versus 17.0%, P = 0.006) and composite perinatal morbidity (43.5 versus 14.9%, P = 0.009). Logistic regression revealed the only independent predictors of spontaneous preterm birth <35 weeks were further cervical length shortening (adjusted odds ratio (aOR) 5.73; 95% confidence interval (CI) 1.31 to 24.43) and gestational age at short cervical length (aOR 0.95; 95% CI 0.91 to 0.99).
CONCLUSION: Further cervical length shortening in asymptomatic high-risk women with a short cervical length is an important independent predictor of spontaneous preterm birth <35 weeks and perinatal morbidity.

Entities:  

Mesh:

Year:  2010        PMID: 21183925     DOI: 10.1038/jp.2010.149

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  4 in total

1.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

Review 2.  Predictive accuracy of changes in transvaginal sonographic cervical length over time for preterm birth: a systematic review and metaanalysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2015-06-10       Impact factor: 8.661

3.  Do serial measurements of cervical length improve the prediction of preterm birth in asymptomatic women with twin gestations?

Authors:  Nir Melamed; Alex Pittini; Liran Hiersch; Yariv Yogev; Steven J Korzeniewski; Roberto Romero; Jon Barrett
Journal:  Am J Obstet Gynecol       Date:  2016-06-27       Impact factor: 8.661

4.  First-trimester vaginal microbiome diversity: A potential indicator of preterm delivery risk.

Authors:  Mohammed Monzoorul Haque; Mitali Merchant; Pinna Nishal Kumar; Anirban Dutta; Sharmila S Mande
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.